Literature DB >> 14700404

Outcomes of Hickman catheter salvage in febrile neutropenic cancer patients with Staphylococcus aureus bacteremia.

Sung-Han Kim1, Cheol-In Kang, Hong-Bin Kim, Sung-Soo Youn, Myoung-don Oh, Eui-Chong Kim, Seon-Yang Park, Byoung-Kook Kim, Kang-Won Choe.   

Abstract

OBJECTIVE: To evaluate the outcome of attempted Hickman catheter salvage in neutropenic cancer patients with Staphylococcus aureus bacteremia who were not using antibiotic lock therapy.
DESIGN: Retrospective cohort study.
SETTING: A university-affiliated, tertiary-care hospital with 1,500 beds for adult patients. PATIENTS: All neutropenic cancer patients who had a Hickman catheter and S. aureus bacteremia (32 episodes in 29 patients) between January 1998 and March 2002.
METHODS: Salvage attempts were defined as cases where the Hickman catheter was not removed until we obtained the results of follow-up blood cultures performed 48 to 72 hours after starting treatment with antistaphylococcal antibiotics. Salvage was considered to be successful if the Hickman catheter was still in place 3 months later without recurrent bacteremia or death.
RESULTS: Catheter salvage was attempted in 24 (75%) of the 32 episodes. Of the salvage attempts, the success rate was 50% (12 of 24). Salvage attempts were successful in 14% (1 of 7) of the episodes with positive follow-up blood cultures, and in 65% (11 of 17) of those with negative follow-up blood cultures (P = .07). If the analysis is confined to cases with no external signs of catheter infection, salvage attempts were successful in 14% (1 of 7) of the episodes with positive follow-up blood cultures and in 80% (8 of 10) of those with negative follow-up blood cultures (P = .02).
CONCLUSION: In neutropenic cancer patients with S. aureus bacteremia, attempted catheter salvage without antibiotic lock therapy was successful in 50% of the cases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14700404     DOI: 10.1086/502157

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  7 in total

1.  Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia.

Authors:  Sung-Han Kim; Kye-Hyung Kim; Hong-Bin Kim; Nam-Joong Kim; Eui-Chong Kim; Myoung-don Oh; Kang-Won Choe
Journal:  Antimicrob Agents Chemother       Date:  2007-11-05       Impact factor: 5.191

2.  In Vitro Study To Evaluate the Bioactivity of Freezing a Heparin-Based Dalbavancin Lock Solution.

Authors:  Marta Rubia; Andrea Cordero; María Jesús Pérez-Granda; Emilia Cercenado; Cristina Pascual; Patricia Muñoz; María Guembe
Journal:  Antimicrob Agents Chemother       Date:  2020-11-17       Impact factor: 5.191

3.  Practical approach to catheter-related bloodstream infections in paediatrics.

Authors:  Joan Robinson
Journal:  Paediatr Child Health       Date:  2005-10       Impact factor: 2.253

Review 4.  Evidence-based guidelines for empirical therapy of neutropenic fever in Korea.

Authors:  Dong-Gun Lee; Sung-Han Kim; Soo Young Kim; Chung-Jong Kim; Wan Beom Park; Young Goo Song; Jung-Hyun Choi
Journal:  Korean J Intern Med       Date:  2011-06-01       Impact factor: 3.165

5.  Clinical outcomes of antimicrobial lock solutions used in a treatment modality: a retrospective case series analysis.

Authors:  P Brandon Bookstaver; Katherine R Gerrald; Robert R Moran
Journal:  Clin Pharmacol       Date:  2010-06-17

6.  Salvage Strategy for Long-Term Central Venous Catheter-Associated Staphylococcus aureus Infections in Children.

Authors:  Fanny Alby-Laurent; Cécile Lambe; Agnès Ferroni; Nadège Salvi; David Lebeaux; Morgane Le Gouëz; Martin Castelle; Florence Moulin; Xavier Nassif; Olivier Lortholary; Martin Chalumeau; Julie Toubiana
Journal:  Front Pediatr       Date:  2019-01-25       Impact factor: 3.418

7.  A Dalbavancin Lock Solution Can Reduce Enterococcal Biofilms After Freezing.

Authors:  Marta Díaz-Navarro; Rama Hafian; Irene Manzano; María J Pérez-Granda; Emilia Cercenado; Cristina Pascual; Carmen Rodríguez; Patricia Muñoz; María Guembe
Journal:  Infect Dis Ther       Date:  2022-01-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.